{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:50:42Z","timestamp":1747155042697,"version":"3.40.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ancard.2018.08.024","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T09:37:18Z","timestamp":1538645838000},"page":"80-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u00c9valuation de la qualit\u00e9 de l\u2019anticoagulation au long cours par antivitamine-K dans la fibrillation auriculaire"],"prefix":"10.1016","volume":"68","author":[{"given":"O.","family":"Ben Rejeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Brahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1269-8816","authenticated-orcid":false,"given":"H.","family":"Ghali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ernez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mahdhaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Jeridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.ancard.2018.08.024_bib0180","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016\u00a0ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.ancard.2018.08.024_bib0185","first-page":"e270","article-title":"2014\u00a0AHA\/ACC\/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ancard.2018.08.024_bib0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1212\/01.wnl.0000250340.05202.8b","article-title":"The increasing incidence of anticoagulant-associated intracerebral hemorrhage","volume":"68","author":"Flaherty","year":"2007","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ancard.2018.08.024_bib0195","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/europace\/eur126","article-title":"Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on thrombosis","volume":"13","author":"Lip","year":"2011","journal-title":"Europace"},{"issue":"11","key":"10.1016\/j.ancard.2018.08.024_bib0200","doi-asserted-by":"crossref","first-page":"e0188482","DOI":"10.1371\/journal.pone.0188482","article-title":"The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: a systematic review and meta-regression analysis","volume":"12","author":"Vestergaard","year":"2017","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.ancard.2018.08.024_bib0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1023\/B:THRO.0000011377.78585.63","article-title":"Quality assessment of anticoagulation dose management: comparative evaluation of measures of time in therapeutic range","volume":"15","author":"Schmitt","year":"2003","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"10.1016\/j.ancard.2018.08.024_bib0210","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archinte.167.3.239","article-title":"Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V","volume":"167","author":"White","year":"2007","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.ancard.2018.08.024_bib0215","first-page":"190","article-title":"Traitement anticoagulant oral \u2013 \u00e9valuation des connaissances des patients","volume":"12","author":"Samoud","year":"2016","journal-title":"Cardiol Tunis"},{"issue":"2","key":"10.1016\/j.ancard.2018.08.024_bib0220","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ancard.2018.08.024_bib0225","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HASBLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1016\/j.ancard.2018.08.024_bib0230","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1538-7836.2011.04302.x","article-title":"Stroke in atrial fibrillation: epidemiology and thromboprophylaxis","volume":"9","author":"Lip","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.ancard.2018.08.024_bib0235","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"issue":"19","key":"10.1016\/j.ancard.2018.08.024_bib0240","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"issue":"36","key":"10.1016\/j.ancard.2018.08.024_bib0245","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017\u00a0ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ancard.2018.08.024_bib0250","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.joa.2013.03.002","article-title":"The APHRS's 2013\u00a0statement on antithrombotic therapy of patients with nonvalvular atrial fibrillation","volume":"29","author":"Ogawa","year":"2013","journal-title":"J Arrhythmia"},{"issue":"6","key":"10.1016\/j.ancard.2018.08.024_bib0255","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1055\/s-0037-1615385","article-title":"Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?","volume":"80","author":"Barcellona","year":"1998","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ancard.2018.08.024_bib0260","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","article-title":"Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review","volume":"1","author":"Wan","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"9921","key":"10.1016\/j.ancard.2018.08.024_bib0265","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ancard.2018.08.024_bib0270","doi-asserted-by":"crossref","first-page":"286","DOI":"10.11604\/pamj.2014.19.286.5411","article-title":"\u00c9valuation du niveau de connaissance des patients sur la gestion du traitement par les antis vitamines K dans le service de cardiologie de Ouagadougou","volume":"19","author":"Samadoulougou","year":"2014","journal-title":"Pan Afr Med J"},{"year":"2010","series-title":"\u00c9valuation des connaissances sur leur traitement des patients trait\u00e9s par antivitamine K et int\u00e9r\u00eat de l\u2019auto-mesure de l\u2019International Normalized Ratio (INR)","author":"Travert","key":"10.1016\/j.ancard.2018.08.024_bib0275"},{"journal-title":"Modalit\u00e9s de prescription des anticoagulants et connaissance des patients de leur traitement","year":"2018","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9","key":"10.1016\/j.ancard.2018.08.024_bib0280"},{"issue":"6","key":"10.1016\/j.ancard.2018.08.024_bib0285","first-page":"713","article-title":"Anticoagulation clinics: the Italian experience","volume":"82","author":"Berrettini","year":"1997","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.ancard.2018.08.024_bib0290","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0897190011431638","article-title":"Factors affecting warfarin related knowledge and INR control of patients attending physicians and pharmacists\u2019 managed anticoagulation clinics","volume":"25","author":"Beyan","year":"2012","journal-title":"J Pharm Pract"},{"issue":"3","key":"10.1016\/j.ancard.2018.08.024_bib0295","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00005082-200605000-00003","article-title":"Factors influencing patient knowledge of warfarin therapy after mechanical heart valve replacement","volume":"21","author":"Hu","year":"2006","journal-title":"J Cardiovasc Nurs"},{"issue":"5","key":"10.1016\/j.ancard.2018.08.024_bib0300","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT2R2\u00a0score","volume":"144","author":"Apostolakis","year":"2013","journal-title":"Chest"},{"issue":"23","key":"10.1016\/j.ancard.2018.08.024_bib0305","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ancard.2018.08.024_bib0310","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/j.1538-7836.2010.03996.x","article-title":"Patient characteristics associated with oral anticoagulation control: results of the Veterans Affairs Study to Improve Anticoagulation (VARIA)","volume":"8","author":"Rose","year":"2010","journal-title":"J Thromb Haemos"},{"issue":"4","key":"10.1016\/j.ancard.2018.08.024_bib0315","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2141.2004.05074.x","article-title":"The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation","volume":"126","author":"Khan","year":"2004","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.ancard.2018.08.024_bib0320","doi-asserted-by":"crossref","first-page":"e74037","DOI":"10.1371\/journal.pone.0074037","article-title":"Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial","volume":"8","author":"Clarkesmith","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ancard.2018.08.024_bib0325","first-page":"595","article-title":"The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR","volume":"16","author":"\u00c7elik","year":"2016","journal-title":"Anatol J Cardiol"},{"journal-title":"Les anticoagulants en France en 2014\u00a0: \u00e9tat des lieux, synth\u00e8se et surveillance","year":"2014","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9","key":"10.1016\/j.ancard.2018.08.024_bib0330"},{"issue":"11","key":"10.1016\/j.ancard.2018.08.024_bib0335","first-page":"169","article-title":"Les accidents h\u00e9morragiques graves sous antivitamines K\u00a0: \u00e9tude descriptive et pronostique","volume":"87","author":"Ben Ameur","year":"2009","journal-title":"Tunis Med"},{"issue":"2","key":"10.1016\/j.ancard.2018.08.024_bib0340","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1161\/CIRCOUTCOMES.115.002366","article-title":"Reimagining anticoagulation clinics in the era of direct oral anticoagulants","volume":"9","author":"Barnes","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"10.1016\/j.ancard.2018.08.024_bib0345","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2141.2005.05899.x","article-title":"A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing","volume":"132","author":"Gardiner","year":"2006","journal-title":"Br J Haematol"},{"issue":"9508","key":"10.1016\/j.ancard.2018.08.024_bib0175","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(06)68139-7","article-title":"Self-monitoring of oral anticoagulation: a systematic review and meta-analysis","volume":"367","author":"Heneghan","year":"2006","journal-title":"Lancet"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392818301240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392818301240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T20:10:39Z","timestamp":1552680639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003392818301240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0003392818301240"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2018.08.024","relation":{},"ISSN":["0003-3928"],"issn-type":[{"type":"print","value":"0003-3928"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9valuation de la qualit\u00e9 de l\u2019anticoagulation au long cours par antivitamine-K dans la fibrillation auriculaire","name":"articletitle","label":"Article Title"},{"value":"Annales de Cardiologie et d'Ang\u00e9iologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ancard.2018.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}